New HIV cocktail aims for remission without daily pills
NCT ID NCT03619278
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This study tested whether a combination of a therapeutic vaccine, a broadly neutralizing antibody (10-1074), and a drug called romidepsin could help people with HIV achieve remission, meaning they could stop their daily antiretroviral therapy without the virus rebounding. The trial was designed for adults with well-controlled HIV on stable treatment. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.